ReviewGlobal spine journal2026
Surgical Outcomes of Degenerative Cervical Myelopathy in Patients with Parkinson Disease: A Systematic Review.
Review in Global spine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study DesignSystematic review.ObjectivesTo synthesize outcomes, complications, and healthcare utilization after surgery for degenerative cervical myelopathy (DCM) in patients with Parkinson disease (PD).MethodsPubMed/MEDLINE, EMBASE, and the Cochrane Library were searched from inception to March 2026. Eligible studies evaluated adults with PD undergoing cervical decompression with or without fusion for DCM; studies not specifically defining myelopathy but reporting cervical outcomes within broader PD spine cohorts were retained as indirect supportive evidence. Two reviewers independently screened studies, extracted data, and appraised quality using standard checklists. Because of marked heterogeneity, findings were synthesized narratively, with greater weight given to myelopathy-defined cohorts.ResultsEleven studies were included: 5 myelopathy-defined cohorts and 6 supportive studies. In myelopathy-defined cohorts, PD patients improved after surgery, but some studies showed smaller gains in modified Japanese Orthopaedic Association (mJOA) or Nurick scores, lower odds of clinically important mJOA improvement, and less EQ-5D improvement compared with non-PD controls. Database studies showed higher complication rates, longer hospital stays, non-home discharge, and a dysphagia/aspiration signal. Supportive studies suggested similar increases in hospitalization and medical complications and raised concern for long-term mechanical failure or reoperation.ConclusionsThe most direct evidence suggests that patients with PD undergoing surgery for cervical myelopathy may improve neurologically, although functional recovery may be smaller or less clinically meaningful in some cohorts. Perioperative risk and healthcare utilization also appear higher. Indirect supportive evidence further suggests that dysphagia or aspiration-related events and long-term mechanical failure or reoperation are important concerns in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.